Response Pharmaceuticals
7 clinical trials · Sponsor
◉ Watch Response Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists (NCT06640972) | Response Pharmaceuticals | 2024-09-27 |
Track Response Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.